Explorer les evidences

0,432 h_squaredThe combined APOBEC somatic mutation signatures had a significant heritable component (h² = 0.432, p = 0.042).

Nigeriacancer du seinpublié 2019International journal of cancereurope_pmcdocument de 4 observations

7 %Each additional 1-year delay before the last full-term pregnancy increased breast cancer odds by 7% in all women.

Nigeriacancer du seinpublié 2022Cancer causes & control : CCCPubMeddocument de 7 observations

45 %45% of participants cited family history as the most recognized breast cancer risk factor.

Nigeriacancer du seinpublié 2024Journal of the Egyptian National Cancer InstitutePubMeddocument de 3 observations

49,2 %49.2% of the respondents had encouraged their female partners to screen for breast cancer.

Nigeriacancer du seinobservé 2018publié 2023PloS onePubMeddocument de 14 observations

10,3 odds_ratioOdds ratio for BRCA2 was 10.3 (95% CI, 3.7 to 28.5).

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

0,04 p-valuePracticing breast self-examination increased early detection (p-value = 0.04).

Nigeriacancer du seinpublié 2021PloS onePubMeddocument de 6 observations

39,4 %Steroid hormone receptor positivity was 39.4%.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

2,25 aORBiopsy-confirmed benign breast disease was associated with breast cancer, with an adjusted odds ratio of 2.25 (95% CI 1.26–4.02).

Nigeriabenign breast disease · cancer du seinpublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

CRP/albumin ratio was significantly associated with Subjective Global Assessment (SGA) categories in breast cancer patients (p < 0.001).

Nigeriacancer du seinobservé January and June 2018publié 2022Nutrition and cancerPubMeddocument de 7 observations

16,4 scoreThe post-intervention overall symptom domain score was 16.4 ± 10.2 for the intervention group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

Glasgow Prognostic Score (GPS) was significantly associated with Subjective Global Assessment (SGA) categories in breast cancer patients (p < 0.001).

Nigeriacancer du seinobservé January and June 2018publié 2022Nutrition and cancerPubMeddocument de 7 observations

1,21 odds_ratioA polygenic model using eight best markers showed a per-allele odds ratio of 1.21 with a 95% confidence interval of 1.16–1.27 and a p-value of 9.7 × 10^(−16) for breast cancer risk prediction in women of African ancestry.

Nigeriacancer du seinpublié 2013Carcinogenesiseurope_pmcdocument de 4 observations

86,7 %Among 45 breast cancer patients assessed between January and June 2018, 86.7% had high levels of erythrocyte sedimentation rate (ESR).

Nigeriacancer du seinobservé January and June 2018publié 2022Nutrition and cancerPubMeddocument de 7 observations

10,3 monthsThe follow-up period for breast cancer patients ranged between 1 and 44 months, with a mean of 10.3 months.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

54,9 %54.9% of respondents were employed in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

15 %15% of the tumors were HER2 positive/ER negative.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

51 %Of 195 health care professionals, 100 (51%) routinely consulted breast cancer guidelines.

Nigeriacancer du seinpublié 2025JAMA network openPubMeddocument de 8 observations

94,8 %Breast cancer awareness was 94.80% among female students and staff of six educational institutions in Ota, Southwest Nigeria.

Nigeriacancer du seinpublié 2023African journal of reproductive healthPubMeddocument de 10 observations

330 casesA total of 330 cases of histologically confirmed breast cancer were evaluated.

Nigeriacancer du seinobservé 2019 and 2021publié 2024West African journal of medicinePubMeddocument de 13 observations

13,8 %Africans showed the lowest frequency of the rs799917 G allele at 13.8%.

Nigeriacancer du seinpublié 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 7 observations

1,07 odds_ratioHeight was associated with non-statistically significant increased odds of breast cancer (adjusted OR: 1.07; 95% CI: 0.90, 1.28).

Nigeriacancer du seinpublié 2021BMC cancerPubMeddocument de 5 observations

92,1 %Breast cancer awareness increased to 92.1% at the 12-month mark in three randomly-selected schools in Southeast Nigeria.

Nigeriacancer du seinpublié 2025Journal of health, population, and nutritionPubMeddocument de 6 observations

14,7 %Among all cases, 14.7% (167 of 1,136) carried a loss-of-function mutation in a breast cancer gene.

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

49,9 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, surgery was performed on 49.9% (303/607) of patients.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

Breast cancer is the second most common cancer in women aged 15–45 after non-melanoma skin cancer.

Nigeriacancer du seinpublié 2021Journal of cancer education : the official journal of the American Association for Cancer PubMeddocument de 3 observations